Simon Barry J. sold IBRX

February 23, 2026 · Form 4 insider transaction

Simon Barry J. sold 165,000 shares of ImmunityBio, Inc. at $10.25 per share, a transaction worth $1.69M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.

Direction
Disposed (sell-side)
Shares
165,000
Price
$10.25
Total value
$1.69M
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 23, 2026
Filing dateFebruary 24, 2026
Shares owned after2,925,821
OwnershipDirect
10b5-1 planYes
AmendedNo

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 4, 2024.; Represents the weighted average share price of an aggregate total of 165,000 shares sold in the price range of $9.89 to $10.635 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

View the original Form 4 on SEC EDGAR
Simon Barry J. sold IBRX: February 23, 2026 | Insider Trading Screener